Hot Pursuit     08-Jul-24
Zydus Lifesciences Ltd spurts 0.43%, up for five straight sessions
Zydus Lifesciences Ltd is quoting at Rs 1167.45, up 0.43% on the day as on 12:44 IST on the NSE. The stock is up 100.73% in last one year as compared to a 25.49% gain in NIFTY and a 48.09% gain in the Nifty Pharma.

Zydus Lifesciences Ltd rose for a fifth straight session today. The stock is quoting at Rs 1167.45, up 0.43% on the day as on 12:44 IST on the NSE. The benchmark NIFTY is down around 0.14% on the day, quoting at 24289.55. The Sensex is at 79913.8, down 0.1%. Zydus Lifesciences Ltd has added around 7.5% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has added around 2.99% in last one month and is currently quoting at 20453.85, down 0.43% on the day. The volume in the stock stood at 10.23 lakh shares today, compared to the daily average of 16.22 lakh shares in last one month.

The benchmark July futures contract for the stock is quoting at Rs 1169.9, up 0.37% on the day. Zydus Lifesciences Ltd is up 100.73% in last one year as compared to a 25.49% gain in NIFTY and a 48.09% gain in the Nifty Pharma index.

The PE of the stock is 33.92 based on TTM earnings ending March 24.

Previous News
  Sensex gains 239 pts; metal shares shine; VIX rallies 3.35%
 ( Market Commentary - Mid-Session 31-Jul-24   12:33 )
  Barometers end with minor gains; broader mkt outperforms
 ( Market Commentary - Quick Review 18-May-24   12:44 )
  Zydus receives USFDA tentative approval for Letermovir tablets
 ( Corporate News - 23-Mar-24   14:00 )
  Zydus receives USFDA approval for Theophylline ER Tablets
 ( Corporate News - 22-May-24   12:57 )
  Zydus and Dr Reddy's ink licensing agreement to co-market Pertuzumab in India
 ( Corporate News - 28-Jun-24   19:04 )
  Zydus Life gets US FDA nod for seizure treatment drug Lacosamide
 ( Hot Pursuit - 16-Dec-23   15:37 )
  Zydus receives USFDA final approval for Chlorpromazine Hydrochloride Injection
 ( Corporate News - 14-Mar-24   12:24 )
  Zydus Life’s Ahmedabad facility gets EIR from USFDA
 ( Hot Pursuit - 01-Oct-24   12:13 )
  Zydus Lifesciences Ltd spurts 7.01%, up for third straight session
 ( Hot Pursuit - 12-Feb-24   13:05 )
  Zydus Life gets US FDA approval for antiretroviral medication Darunavir
 ( Hot Pursuit - 15-Dec-23   09:42 )
  Zydus Board approves business transfer agreement for acquisition of API biz of Sterling Biotech
 ( Corporate News - 17-Sep-24   12:04 )
Other Stories
  Avantel Q2 PAT jumps 42% YoY to Rs 23 cr
  05-Oct-24   17:03
  Equitas SFB total deposits jump 29% YoY in Q2 FY25
  05-Oct-24   16:28
  Ujjivan SFB total deposits rises 17% in Q2 FY25
  05-Oct-24   15:34
  L&T Finance retail disbursements jump 12% YoY in Q2 FY25
  05-Oct-24   14:31
  Bandhan Bank records over 21% YoY jump in loan book during Q2 FY25; deposits at Rs 1.42 lakh crore
  05-Oct-24   13:32
  Lupin's Pune-based biotech facility gets 5 observations from US FDA
  05-Oct-24   13:20
  Macrotech Developers pre-sales jumps 21% YoY in Q2 FY25
  05-Oct-24   09:04
  UCO Bank’s total advances jump 19% YoY in Q2 FY25
  04-Oct-24   15:15
  Vakrangee Ltd leads losers in 'A' group
  04-Oct-24   15:00
  Kamdhenu Ventures Ltd leads losers in 'B' group
  04-Oct-24   14:45
Back Top